Suggested Topics within your search.
Showing 61 - 80 results of 95 for search '"Cancer immunology"', query time: 0.06s Refine Results
  1. 61
    Emerging insights into intravital imaging, unraveling its role in cancer immunotherapy

    Emerging insights into intravital imaging, unraveling its role in cancer immunotherapy by Minfeng Yang, Shiqiang Hou, Yao Chen, Hongzhao Chen, Minjie Chu, Song-Bai Liu

    Published 2025-02-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 62
    ANKRD22 participates in the proinflammatory activities of macrophages in the colon cancer tumor microenvironment

    ANKRD22 participates in the proinflammatory activities of macrophages in the colon cancer tumor microenvironment by Xiaoying Wang, Keqing Yang, Bin Yang, Rui Wang, Yongliang Zhu, Tianhui Pan

    Published 2025-02-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 63
    Target trial emulation to evaluate the effect of immune-related adverse events on outcomes in metastatic urothelial cancer

    Target trial emulation to evaluate the effect of immune-related adverse events on outcomes in metastatic urothelial cancer by Renate Pichler, Josef Fritz, Sarah Maier, Melanie R. Hassler, Johanna Krauter, David D`Andrea, Ekaterina Laukhtina, Kilian Gust, Keiichiro Mori, Karl H. Tully, Dora Niedersuess-Beke, Lea Korber, Jasmin Alija Spiegelberg, Thomas Bauernhofer, José D. Subiela, Roman Mayr, Andreas Kronbichler, Marco Moschini, Jeremy Teoh, Benjamin Pradere, Shahrokh F. Shariat, Hanno Ulmer, Laura S. Mertens, European Association of Urology–Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group

    Published 2024-12-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 64
    Immunological differences between monophasic and biphasic synovial sarcoma with implications for immunotherapy

    Immunological differences between monophasic and biphasic synovial sarcoma with implications for immunotherapy by S. J. Luk, M. E. IJsselsteijn, A. Somarakis, I. Acem, I. Briaire de Bruijn, K. Szuhai, J. V. M. G. Bovee, N. F. C. C. de Miranda, J. H. F. Falkenburg, M. H. M. Heemskerk

    Published 2024-12-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 65
    Targeting HVEM-GPT2 axis: a novel approach to T cell activation and metabolic reprogramming in non-small cell lung cancer therapy

    Targeting HVEM-GPT2 axis: a novel approach to T cell activation and metabolic reprogramming in non-small cell lung cancer therapy by Yuanshan Yao, Chunji Chen, Bin Li, Wen Gao

    Published 2025-02-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 66
    COVID-19–sensitive tumour response: 2-year assessment of the SARS-CoV-2 humoral response in cancer patients in oncology hospital in Poland

    COVID-19–sensitive tumour response: 2-year assessment of the SARS-CoV-2 humoral response in cancer patients in oncology hospital in Poland by Piotr Kosiorek, Bożena Mikołuć, Samuel Stróż, Anna Hryniewicz, Dorota E. Kazberuk, Robert Milewski, Anna Grzeszczuk, Magdalena J. Borkowska, Anna Stasiak‐Barmuta

    Published 2024-12-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 67
    Efficacy of PD-1 blockade plus chemotherapy in patients with oncogenic-driven non-small-cell lung cancer

    Efficacy of PD-1 blockade plus chemotherapy in patients with oncogenic-driven non-small-cell lung cancer by Haowei Wang, Lei Cheng, Jian Chen, Peixin Chen, Zhuoran Tang, Qianyi Wang, Ying Ma, Chao Zhao, Xuefei Li, Tao Jiang, Fei Zhou, Xiaoxia Chen, Caicun Zhou

    Published 2025-02-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 68
    Cryo-thermal therapy reshaped the tumor immune microenvironment to enhance the efficacy of adoptive T cell therapy

    Cryo-thermal therapy reshaped the tumor immune microenvironment to enhance the efficacy of adoptive T cell therapy by Shicheng Wang, Peng Peng, Junjun Wang, Zelu Zhang, Ping Liu, Lisa X. Xu

    Published 2024-11-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 69
    Integrated multi-omics analysis reveals clinical significance of hepatocyte nuclear factor-1β in tumor immune microenvironment, immunotherapy and prognostic prediction for colon adenocarcinoma

    Integrated multi-omics analysis reveals clinical significance of hepatocyte nuclear factor-1β in tumor immune microenvironment, immunotherapy and prognostic prediction for colon ad... by Fushan Gao, Wenlin Gong, Haihua He, Zhen Zhang, Hongcai Yang, Fei Shao, Yibo Gao, Jie He

    Published 2024-12-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 70
    CD155 promotes the progression of colorectal cancer by restraining CD8+ T cells via the PI3K/AKT/NF-κB pathway

    CD155 promotes the progression of colorectal cancer by restraining CD8+ T cells via the PI3K/AKT/NF-κB pathway by Rongpu Liang, Liting Liu, Dongbing Ding, Yiquan Li, Jiannan Ren, Bo Wei

    Published 2025-02-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 71
    Overcoming immunosuppression in cancer: how ketogenic diets boost immune checkpoint blockade

    Overcoming immunosuppression in cancer: how ketogenic diets boost immune checkpoint blockade by Victoria E. Stefan, Daniela D. Weber, Roland Lang, Barbara Kofler

    Published 2024-11-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 72
    HLA-G high-expressor 3’UTR markers are linked to gastric cancer development and survival

    HLA-G high-expressor 3’UTR markers are linked to gastric cancer development and survival by Christian Vaquero-Yuste, Ignacio Juarez, Marta Molina-Alejandre, Elisa María Molanes-López, Alberto Gutiérrez-Calvo, Adela López-García, Inmaculada Lasa, Remedios Gómez, Antonio Arnaiz-Villena, Jose Manuel Martín-Villa

    Published 2024-11-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 73
    Combination of ataxia telangiectasia and Rad3-related inhibition with ablative radiotherapy remodels the tumor microenvironment and enhances immunotherapy response in lung cancer

    Combination of ataxia telangiectasia and Rad3-related inhibition with ablative radiotherapy remodels the tumor microenvironment and enhances immunotherapy response in lung cancer by Jenny Ling-Yu Chen, Chun-Kai Pan, Li-Cheng Lin, Yu-Sen Huang, Tsung-Hsuan Huang, Shu-Jyuan Yang, Sung-Hsin Kuo, Yu-Li Lin

    Published 2024-11-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 74
    Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy

    Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy by Rangarirai Makuku, Neda Khalili, Sepideh Razi, Mahsa Keshavarz-Fathi, Nima Rezaei

    Published 2021-01-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 75
    Multiomics profiling reveals the benefits of gamma-delta (γδ) T lymphocytes for improving the tumor microenvironment, immunotherapy efficacy and prognosis in cervical cancer

    Multiomics profiling reveals the benefits of gamma-delta (γδ) T lymphocytes for improving the tumor microenvironment, immunotherapy efficacy and prognosis in cervical cancer by Xiaofeng Wang, Chen Li, Jie Chen, Zhiqiang Wu, Zhen Zhang, Junyi Li, Lu Yu, Yong Guan, Yuhan Zhang, Yuanjie Cao, Yancheng Liu, Hui Bai, Shaochuan Liu, Miaomiao Gao, Chenglu Lu, Zhen Tao, Zhiyong Yuan

    Published 2024-01-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 76
    A literature review of recent advances in gastric cancer treatment: exploring the cross-talk between targeted therapies

    A literature review of recent advances in gastric cancer treatment: exploring the cross-talk between targeted therapies by Reza Panahizadeh, Padideh Panahi, Vahid Asghariazar, Shima Makaremi, Ghasem Noorkhajavi, Elham Safarzadeh

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 77
    Osimertinib exacerbates immune checkpoint inhibitor-related severe adverse events by activating the IL-6/JAK/STAT3 pathway in macrophages

    Osimertinib exacerbates immune checkpoint inhibitor-related severe adverse events by activating the IL-6/JAK/STAT3 pathway in macrophages by Yuan Li, Yanping Chen, Yuan Meng, Meng Shen, Fan Yang, Xiubao Ren

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 78
    Panitumumab plus 5-fluorouracil and folinic acid or 5-fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212): final efficacy analysis of a randomised, open-label, phase 2 trialResearch in context

    Panitumumab plus 5-fluorouracil and folinic acid or 5-fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212... by Arndt Stahler, Meinolf Karthaus, Stefan Fruehauf, Ullrich Graeven, Lothar Müller, Ludwig Fischer von Weikersthal, Karel Caca, Eray Goekkurt, Alexej Ballhausen, Greta Sommerhäuser, Annabel H.S. Alig, Swantje Held, Armin Jarosch, David Horst, Anke Reinacher-Schick, Stefan Kasper, Volker Heinemann, Sebastian Stintzing, Tanja Trarbach, Dominik P. Modest

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 79
    Cellular aspects of immunity involved in the development of atherosclerosis

    Cellular aspects of immunity involved in the development of atherosclerosis by Khalil Khalaf, Khalil Khalaf, Khalil Khalaf, Marc Chamieh, Natalia Welc, Chandpreet Singh, Joanne Lynn Kaouk, Aiden Kaouk, Andrzej Mackiewicz, Andrzej Mackiewicz, Mariusz Kaczmarek, Mariusz Kaczmarek, Bartlomiej Perek

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  20. 80
    Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders

    Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders by Jeffrey A Meyerhardt, Sunil Kumar, Jessica A Zerillo, Aparna Parikh, James M Cleary, Scott Rodig, Benjamin Schlechter, Kimmie Ng, Stephanie K Dougan, Nora Horick, Glenn J Hanna, Andrew L Coveler, Anuj K Patel, Nadine J McCleary, Douglas A Rubinson, Jeffrey W Clark, Kent Mouw, Kathleen Pfaff, Thomas A Abrams, Matthew B Yurgelun, Eliezer M Van Allen, S Jennifer Wang, Leah H Biller, Harshabad Singh, Emma L Welsh, Brandon M Huffman, Lestat R Ali, Megan T Hoffman, Katherine A Metayer, Shayla Murray, Alexandra Bird, Jennifer A Chan, Wolfram Goessling, Jeffrey S Wisch, Brendan Reardon, Robert J Mayer, Catherine Del Vecchio Fitz, Charlotte Kuperwasser

    Published 2024-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: